Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD
ClinicalTrials.gov study NCT03256552. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03398148. IPD Sharing: YES. Countries: 44. Publications: 4.
A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe Psoriasis
ClinicalTrials.gov study NCT02387801. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis
ClinicalTrials.gov study NCT03813199. IPD Sharing: NO. Countries: 5. Publications: 1.
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
ClinicalTrials.gov study NCT01854047. IPD Sharing: Not stated. Countries: 16. Publications: 8.
A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov study NCT00322153. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)
ClinicalTrials.gov study NCT04518995. IPD Sharing: NO. Countries: 5. Publications: 0.
A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT00615199. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Study in Adult Patients With Moderate to Severe Asthma
ClinicalTrials.gov study NCT04886999. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT03782376. IPD Sharing: YES. Countries: 12. Publications: 2.
Propofol vs. Midazolam-based Balanced Propofol for Nonanesthesiologist Moderate Sedation in Colonoscopy
ClinicalTrials.gov study NCT01428882. IPD Sharing: YES. Countries: 1. Publications: 18.
A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05601882. IPD Sharing: YES. Countries: 29. Publications: 1.
Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03334422. IPD Sharing: YES. Countries: 10. Publications: 6.
Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects
ClinicalTrials.gov study NCT01708629. IPD Sharing: YES. Countries: 11. Publications: 6.
Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise
ClinicalTrials.gov study NCT00819767. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy
ClinicalTrials.gov study NCT01500226. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs
ClinicalTrials.gov study NCT01578850. IPD Sharing: Not stated. Countries: 19. Publications: 3.
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
ClinicalTrials.gov study NCT02580305. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Moderately Preterm Infants With Caffeine at Home for Apnea (MoCHA) Trial
ClinicalTrials.gov study NCT03340727. IPD Sharing: YES. Countries: 1. Publications: 1.
Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)
ClinicalTrials.gov study NCT03134222. IPD Sharing: NO. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.